Josh Enomoto

Josh Enomoto

Brokering multi-million-dollar deals with some of the world’s biggest companies and providing in-depth marketing analyses, Josh Enomoto takes his firsthand knowledge of the corporate boardroom and delivers them across several media outlets. In addition to his work at InvestorPlace, Josh contributes content for Benzinga, TipRanks, EmergingGrowth and Blockster. He is also a guest expert at CGTN America.

While leaving no stone unturned regarding sector coverage, Josh has written extensively about cryptocurrencies. You can follow him on Blockster, a crypto-centric social media platform and on LinkedIn.

Recent Articles

Hold Off on eFFECTOR Therapeutics if You Can’t Stomach the Risk

While EFTR stock has escaped the usual underperformance of SPAC IPOs so far, eFFECTOR Therapeutics still remains a risky proposition.

It’s Time for a Level-Headed Approach to Bitcoin

While Bitcoin has been one of the biggest stories of 2021, the narrative is looking stretched, which suggests a cautionary approach.

7 Best Stocks to Buy for the California Recall Results

With Governor Newsom securing his job after a controversial recall election, these stocks to buy may benefit the most.

The Allure and the Very Real Pitfall of Algorand

While Algorand represents an extraordinary paradigm shift in finance and economics, it could also go very sour very quickly.

Headed in Its Own Direction, Shiba Inu Truly Does Have a Mind of Its Own

While most cryptos are frustratingly tied to Bitcoin’s pricing trends, Shiba Inu is completely disassociated from this benchmark. The SHIB-USD correlation is no more.

7 Companies Set to IPO That Could Be the Next Big Thing

While the market for IPOs is always risky and unpredictable, it’s an enticing sector that can potentially facilitate massive gains.

7 Materials Stocks to Buy as Investors Look Forward to 2022

With the U.S. looking like the best house in the worst neighborhood, this dynamic could help boost materials stocks.

Buy Lucid Stock as an Acknowledgement That Mass Adoption Is Hard

While some analysts may compare LCID stock to buying Tesla or Ferrari shares, it’s more like acquiring Ford very early on.

Ethereum Holders Face Some Hard Questions Ahead In Unpredictable Market

While Ethereum has made a sizable recovery from its most recent doldrums, significant stakeholders must ask serious questions.

Trading on the Irony of Exela Technologies Could Be Risky

While the bulls may utterly hate those who are bearish on XELA stock, it’s the pessimists that really give shares their fuel.